EMD (EMD) Stock Price & Analysis
EMD (EMD) rose 0.48% to USD 10.46 as of June 10, 2026 at 03:10 UTC, according to Nexqual real-time market data.
EMD last closed at USD 10.41; the session ranged USD 10.35–10.5 on volume of 234,633 shares. Market capitalization is $608.04M, with a 52-week range of USD 9.6–11.3 (NYQ). Source: Nexqual, June 10, 2026 at 03:10 UTC.
Key Statistics (as of June 10, 2026 at 03:10 UTC)
| Price | USD 10.46 |
|---|---|
| Change | ▲ 0.48% (up) |
| Previous Close | USD 10.41 |
| Open | USD 10.44 |
| Day Range | USD 10.35 – 10.5 |
| 52-Week Range | USD 9.6 – 11.3 |
| Volume | 234,633 shares |
| Market Cap | $608.04M |
| Exchange | NYQ |
Technical Analysis (EMD)
Nexqual's technical model rates EMD "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:10 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 44.81 (neutral) |
| vs SMA50 | Below (USD 10.54) |
| MACD | -0.05 (negative) |
Analyst Ratings (EMD)
Wall Street analysts rate EMD "None", per Nexqual as of June 10, 2026 at 03:10 UTC.
| Consensus Rating | None |
|---|
Earnings (EMD)
Source: Nexqual, June 10, 2026 at 03:10 UTC.
Financials & Fundamentals (EMD)
| Total Revenue | $68.09M |
|---|---|
| Revenue Growth (YoY) | -3.00% |
| Gross Margin | +100.00% |
| Operating Margin | +87.08% |
| Profit Margin | +148.51% |
| ROE | +15.93% |
| Debt / Equity | 36.55 |
| Current Ratio | 0.07 |
| Total Cash | $39,708 |
| Total Debt | $238.77M |
| Free Cash Flow | $31.74M |
Source: Nexqual, June 10, 2026 at 03:10 UTC.
Financial Health Score (EMD)
Nexqual rates EMD's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 03:10 UTC.
| Growth | Weak — Revenue -3% YoY (latest Q), declining |
|---|---|
| Profitability | Strong — Operating margin 87% |
| Balance Sheet | Mixed — $40K cash vs $239M debt |
| Cash Flow | Strong — FCF $32M, 47% margin |
| Efficiency | Solid — ROE 16%, ROA 4.3% |
Ownership (EMD)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +45.42% |
| Shares Outstanding | 58.13M |
| Short % of Float | +0.22% |
Source: Nexqual, June 10, 2026 at 03:10 UTC.
Leadership (EMD)
EMD is led by Jane Elizabeth Trust (age 63), Chairman, Chief Executive Officer and President, per Nexqual as of June 10, 2026 at 03:10 UTC.
| Chairman, Chief Executive Officer and President | Jane Elizabeth Trust (age 63) |
|---|
Major Backers & Investors (EMD)
Notable institutional backers of EMD include Morgan Stanley, Invesco, Raymond James Financial, Inc., according to Nexqual as of June 10, 2026 at 03:10 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 15.5% |
| Invesco | 2.43% |
| Raymond James Financial, Inc. | 1.66% |
| Pathstone Holdings, LLC | 1.56% |
| LPL Financial LLC | 1.44% |
| Penserra Capital Management LLC | 1.31% |
| Amplify ETF Trust-Amplify CEF High Income ETF | 1.3% |
| Wells Fargo & Company | 1.29% |
Source: Nexqual, June 10, 2026 at 03:10 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EDF | Stone Harbor Emerging Markets I | USD 5.47 | ▲ 2.63% |
| MSD | Morgan Stanley Emerging Markets | USD 7.23 | ▲ 0.56% |
| EHI | Western Asset Global High Incom | USD 5.93 | ▲ 0.17% |
| TEI | Templeton Emerging Markets Inco | USD 6.3 | ▲ 0.16% |
| AWF | Alliancebernstein Global High I | USD 10.14 | ▲ 0.5% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:10 UTC. This page is informational and not investment advice.